Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.
Higashigawa S, Matsubayashi H, Kiyozumi Y, Kado N, Nishimura S, Oishi T, Sugino T, Fushiki K, Shirasu H, Yasui H, Mamesaya N, Fukuzaki N, Kunitomo K, Horiuchi Y, Kenmotsu H, Serizawa M. Higashigawa S, et al. Among authors: mamesaya n. Jpn J Clin Oncol. 2022 May 31;52(6):599-608. doi: 10.1093/jjco/hyac046. Jpn J Clin Oncol. 2022. PMID: 35411369
The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.
Fujiwara T, Kenmotsu H, Naito T, Kawamura T, Mamesaya N, Kotake M, Kobayashi H, Omori S, Nakashima K, Wakuda K, Ono A, Taira T, Murakami H, Omae K, Mori K, Endo M, Takahashi T. Fujiwara T, et al. Among authors: mamesaya n. Cancer Chemother Pharmacol. 2017 Jun;79(6):1229-1237. doi: 10.1007/s00280-017-3324-7. Epub 2017 Apr 28. Cancer Chemother Pharmacol. 2017. PMID: 28455585
Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy.
Mamesaya N, Wakuda K, Omae K, Miyawaki E, Kotake M, Fujiwara T, Kawamura T, Kobayashi H, Nakashima K, Omori S, Ono A, Kenmotsu H, Naito T, Murakami H, Mori K, Harada H, Endo M, Nakajima T, Takahashi T. Mamesaya N, et al. Oncotarget. 2018 Apr 3;9(25):17664-17674. doi: 10.18632/oncotarget.24830. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707139 Free PMC article.
Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases.
Miyawaki E, Kenmotsu H, Mori K, Harada H, Mitsuya K, Mamesaya N, Kawamura T, Kobayashi H, Nakashima K, Omori S, Wakuda K, Ono A, Naito T, Murakami H, Endo M, Nakasu Y, Gon Y, Takahashi T. Miyawaki E, et al. Among authors: mamesaya n. Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):604-613. doi: 10.1016/j.ijrobp.2019.02.051. Epub 2019 Mar 6. Int J Radiat Oncol Biol Phys. 2019. PMID: 30851347
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
Inoue H, Ono A, Kawabata T, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Kenmotsu H, Naito T, Murakami H, Yasui K, Ogawa H, Onoe T, Endo M, Harada H, Takahashi T. Inoue H, et al. Among authors: mamesaya n. Invest New Drugs. 2020 Oct;38(5):1612-1617. doi: 10.1007/s10637-020-00917-2. Epub 2020 Mar 3. Invest New Drugs. 2020. PMID: 32128667 Free PMC article.
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer.
Miyawaki T, Kenmotsu H, Mori K, Miyawaki E, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Ono A, Naito T, Murakami H, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: mamesaya n. Clin Lung Cancer. 2020 Sep;21(5):e405-e414. doi: 10.1016/j.cllc.2020.02.012. Epub 2020 Feb 26. Clin Lung Cancer. 2020. PMID: 32205040 Clinical Trial.
57 results